214 related articles for article (PubMed ID: 19997488)
21. Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.
Federico M; Portiansky EL; Sommese L; Alvarado FJ; Blanco PG; Zanuzzi CN; Dedman J; Kaetzel M; Wehrens XHT; Mattiazzi A; Palomeque J
J Physiol; 2017 Jun; 595(12):4089-4108. PubMed ID: 28105734
[TBL] [Abstract][Full Text] [Related]
22. Na+ channel regulation by Ca2+/calmodulin and Ca2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes.
Aiba T; Hesketh GG; Liu T; Carlisle R; Villa-Abrille MC; O'Rourke B; Akar FG; Tomaselli GF
Cardiovasc Res; 2010 Feb; 85(3):454-63. PubMed ID: 19797425
[TBL] [Abstract][Full Text] [Related]
23. Relevance of calmodulin/CaMKII activation for arrhythmogenesis in the AV block dog.
Bourgonje VJ; Schoenmakers M; Beekman JD; van der Nagel R; Houtman MJ; Miedema LF; Antoons G; Sipido K; de Windt LJ; van Veen TA; Vos MA
Heart Rhythm; 2012 Nov; 9(11):1875-83. PubMed ID: 22846339
[TBL] [Abstract][Full Text] [Related]
24. In Vivo Post-Cardiac Arrest Myocardial Dysfunction Is Supported by Ca2+/Calmodulin-Dependent Protein Kinase II-Mediated Calcium Long-Term Potentiation and Mitigated by Alda-1, an Agonist of Aldehyde Dehydrogenase Type 2.
Woods C; Shang C; Taghavi F; Downey P; Zalewski A; Rubio GR; Liu J; Homburger JR; Grunwald Z; Qi W; Bollensdorff C; Thanaporn P; Ali A; Riemer K; Kohl P; Mochly-Rosen D; Gerstenfeld E; Large S; Ali Z; Ashley E
Circulation; 2016 Sep; 134(13):961-977. PubMed ID: 27582424
[TBL] [Abstract][Full Text] [Related]
25. Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model.
Hund TJ; Rudy Y
Circulation; 2004 Nov; 110(20):3168-74. PubMed ID: 15505083
[TBL] [Abstract][Full Text] [Related]
26. CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations.
Koval OM; Guan X; Wu Y; Joiner ML; Gao Z; Chen B; Grumbach IM; Luczak ED; Colbran RJ; Song LS; Hund TJ; Mohler PJ; Anderson ME
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4996-5000. PubMed ID: 20194790
[TBL] [Abstract][Full Text] [Related]
27. Factors Promoting Conduction Slowing as Substrates for Block and Reentry in Infarcted Hearts.
Campos FO; Whitaker J; Neji R; Roujol S; O'Neill M; Plank G; Bishop MJ
Biophys J; 2019 Dec; 117(12):2361-2374. PubMed ID: 31521328
[TBL] [Abstract][Full Text] [Related]
28. Slow conduction through an arc of block: A basis for arrhythmia formation postmyocardial infarction.
Patterson E; Scherlag BJ; Berbari EJ; Lazzara R
J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1203-1212. PubMed ID: 28730712
[TBL] [Abstract][Full Text] [Related]
29. CaMKII as a target for arrhythmia suppression.
Mustroph J; Neef S; Maier LS
Pharmacol Ther; 2017 Aug; 176():22-31. PubMed ID: 27742568
[TBL] [Abstract][Full Text] [Related]
30. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.
Swaminathan PD; Purohit A; Hund TJ; Anderson ME
Circ Res; 2012 Jun; 110(12):1661-77. PubMed ID: 22679140
[TBL] [Abstract][Full Text] [Related]
31. [Oxidative stress and calcium/calmodulin-dependent protein kinase II contribute to the development of sustained β adrenergic receptor-stimulated cardiac hypertrophy in rats].
Liu YL; Liu B; Qu YY; Chai HJ; Li R; Zhang L
Sheng Li Xue Bao; 2013 Feb; 65(1):1-7. PubMed ID: 23426507
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of Kv4.3 gene reverses cardiac remodeling and transient-outward K
Tao B; Liu Z; Wei F; Fan S; Cui S; Xia H; Xu L
Biomed Pharmacother; 2020 Dec; 132():110896. PubMed ID: 33254430
[TBL] [Abstract][Full Text] [Related]
33. Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II.
Ma Y; Cheng WT; Wu S; Wong TM
Br J Pharmacol; 2009 Jul; 157(5):705-15. PubMed ID: 19422373
[TBL] [Abstract][Full Text] [Related]
34. Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft.
Dries E; Santiago DJ; Johnson DM; Gilbert G; Holemans P; Korte SM; Roderick HL; Sipido KR
J Physiol; 2016 Oct; 594(20):5923-5939. PubMed ID: 27121757
[TBL] [Abstract][Full Text] [Related]
35. Is CaMKII a link between inflammation and hypertrophy in heart?
Singh MV; Anderson ME
J Mol Med (Berl); 2011 Jun; 89(6):537-43. PubMed ID: 21279501
[TBL] [Abstract][Full Text] [Related]
36. CaMKII-dependent phosphorylation regulates basal cardiac pacemaker function via modulation of local Ca2+ releases.
Li Y; Sirenko S; Riordon DR; Yang D; Spurgeon H; Lakatta EG; Vinogradova TM
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H532-44. PubMed ID: 27402669
[TBL] [Abstract][Full Text] [Related]
37. CaMKII regulation of voltage-gated sodium channels and cell excitability.
Maier LS
Heart Rhythm; 2011 Mar; 8(3):474-7. PubMed ID: 20887805
[No Abstract] [Full Text] [Related]
38. Caveolae-specific activation loop between CaMKII and L-type Ca
Tonegawa K; Otsuka W; Kumagai S; Matsunami S; Hayamizu N; Tanaka S; Moriwaki K; Obana M; Maeda M; Asahi M; Kiyonari H; Fujio Y; Nakayama H
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H501-H514. PubMed ID: 28039202
[TBL] [Abstract][Full Text] [Related]
39. Inhibitor 1 of Protein Phosphatase 1 Regulates Ca
Luo H; Song S; Chen Y; Xu M; Sun L; Meng G; Zhang W
Oxid Med Cell Longev; 2019; 2019():2193019. PubMed ID: 31885777
[TBL] [Abstract][Full Text] [Related]
40. Amelioration of mitochondrial dysfunction in heart failure through S-sulfhydration of Ca
Wu D; Hu Q; Tan B; Rose P; Zhu D; Zhu YZ
Redox Biol; 2018 Oct; 19():250-262. PubMed ID: 30195191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]